Ventus Therapeutics closes $140M series C financing round Ventus Therapeutics closed $140 million in series C financing. The funding will allow the company to scale its Resolve platform to address targets previously considered undruggable and enhance its performance by automating processes, expanding machine-learning capabilities, and constructing larger proprietary virtual libraries.Read More
Seismic Therapeutic launches with $101M series A financing Seismic Therapeutic has launched with $101 million in series A financing to usher in a new era of immunology drug development integrating machine learning, specifically by advancing its Impact platform.Read More
BioAuxilium Research expands its cell-signaling assay portfolio BioAuxilium Research is expanding its no-wash Thunder time-resolved Förster resonance energy transfer technology portfolio by introducing new cell-signaling pathway and biomarker research assay kits, along with a panel of mix-and-match toolbox reagents. The new offering brings the company's portfolio to a total of 104 products.Read More
BioSkryb, ALS Lab Solutions sign U.S. distribution agreement BioSkryb Genomics and ALS Automated Lab Solutions have announced a U.S. distribution agreement to power comprehensive single-cell plus spatial genomic analysis. The agreement was signed in December 2021. The partnership will develop single-cell genome analysis from intact tissue samples.Read More
Applied Cells unveils GMP-ready MARS bar system Applied Cells unveiled its multiphysics automated reconfigurable separation (MARS) good manufacturing practices (GMP)-ready bar system at the Society for Lab Automation and Screening 2022 International Conference and Expo in Boston on February 7.Read More
Congruence Therapeutics announces series A financing Congruence Therapeutics closed a $50 million, tranched, series A financing round to deploy its computational platform for rational drug design and to build a database of mutant proteins.Read More
Novel genetic analyzer advances capabilities of Sanger sequencing Capillary electrophoresis, which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery. To further enable customers' cutting-edge research in areas such as gene editing and infectious disease, Thermo Fisher Scientific has introduced the new Applied Biosystems SeqStudio Flex Series Genetic Analyzer.Read More
Hamilton and Artel collaborate Hamilton and Artel's nearly complete collaboration has resulted in a packaged solution to standardize performance validation of Hamilton's automated liquid handlers. The packaged solution will reduce time and effort compared to assay-specific validation methods. Additionally, it will ensure highly consistent, accurate, and precise results and strengthen the ability to compare performance and results across all Hamilton automated liquid handlers, the companies said.Read More
Seqirus gains new R&D facility for sa-mRNA influenza vaccine technology Seqirus, a business of CSL Limited, has invested in a new R&D facility located in Waltham, MA. The new facility will support the company's growing portfolio for influenza prevention, with a focus on a self-amplifying mRNA (sa-mRNA) technology platform.Read More